Inactive Instrument

Press Releases Amarillo Biosciences, Inc. Other OTC

Equities

AMAR

US02301P2056

Press Releases

Unlock all the news: Be the first to know and act before the market!

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA	Jun. 17	AQ
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market	May. 16	AQ
Ainos : Reports Full Year 2023 Financial Results - Form 8-K	Mar. 08	PU
Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th	Feb. 01	AQ
Ainos Announces $1.75 Million Follow-On Funding	Jan. 25	AQ
Ainos, Inc. Announces Stock Consolidation	Dec. 13	AQ
Ainos : Private Placement - Form 8-K	Nov. 24	PU
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA	Nov. 07	AQ
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement	23-09-26	AQ
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients	23-09-19	NE
Ainos VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients	23-09-19	AQ
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan	23-09-06	AQ
Ainos : PROMISSORY NOTE EXTENSION AGREEMENT - Form 8-K	23-08-22	PU
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond	23-08-15	NE
Ainos Reports Second Quarter 2023 Financial Results	23-08-14	AQ
Ainos Celebrates First Listing Anniversary on Nasdaq	23-08-11	AQ
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform for Broader Industry Adoption	23-08-10	AQ
AINOS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-04-11	AQ
AINOS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-04-03	AQ
AINOS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-03-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amarillo Biosciences, Inc. Other OTC

Equities

AMAR

US02301P2056

Press Releases

Filters